Jasvinder Singh Bhatti
Molecular Biology · 2016–2025
A researcher in the Science corpus: 10 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 81 citations into it
- Biochemistry — 15 citations into it
Whom Jasvinder Singh Bhatti trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Jasvinder Singh Bhatti's perspective
Ordered by how strongly the researchers Jasvinder Singh Bhatti trusts endorse each paper. Same corpus, a different order for every researcher.
- Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.
- Free radicals in the physiological control of cell function. (Physiological Reviews)
- Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. (Nature)
- Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells (Journal of Biological Chemistry)
- Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. (Diabetes)
- Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. (Cell)
- Delivery of bioactive molecules to mitochondria in vivo (Proceedings of the National Academy of Sciences of the United States of America)
- Reactive oxygen species have a causal role in multiple forms of insulin resistance (Nature)
- Targeting antioxidants to mitochondria by conjugation to lipophilic cations. (Annual Review of Pharmacology and Toxicology)
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 (2025) — 602 citations
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) — 1,044 citations
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) — 1,610 citations
- Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 (2024) — 644 citations
- Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) — 859 citations
- Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) — 1,693 citations
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (2023) — 2,755 citations
- Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. (2022) — 599 citations
- Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. (2021) — 777 citations
- Mitochondrial dysfunction and oxidative stress in metabolic disorders - A Step towards mitochondria based therapeutic strategies (2016) — 1,410 citations